1. Different clinicopathological features of hepatocellular carcinoma in relation to causative agents

   • Yasushi Shiratori
   • Haruhiko Yoshida
   • Masao Omata

   Review Pages: 73 - 78

2. Growth inhibition and apoptosis of gastric cancer cell lines by Anemarrhena asphodeloides Bunge

   • Yoshio Takeda
   • Hitoshi Togashi
   • Tsuneo Takahashi

   Pages: 79 - 90

3. Melatonin's gastroprotective and antistress roles involve both central and peripheral effects

   • Kimitoshi Kato
   • Satoshi Asai
   • Yasuyuki Arakawa

   Pages: 91 - 95

4. Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer

   • Hyun Soo Kim
   • Dong Ki Lee
   • Mee Yon Cho

   Pages: 96 - 102

5. Mutation at codon 130 in hepatitis B virus (HBV) core region increases markedly during acute exacerbation of hepatitis in chronic HBV carriers

   • Akihiko Okumura
   • Tetsuya Ishikawa
   • Shinichi Kakumu

   Pages: 103 - 110

6. The sympathetic nervous system promotes carbon tetrachloride-induced liver cirrhosis in rats by suppressing apoptosis and enhancing the growth kinetics of regenerating hepatocytes

   • Koumei Hamasaki
   • Masahiro Nakashima
   • Ichiro Sekine

   Pages: 111 - 120

7. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication

   • Hiroshi Miki
   • Shoji Kobayashi
   • Masaki Ohmori

   Case report Pages: 121 - 124

8. Laparoscopic cholecystofistulectomy for preoperatively diagnosed cholecystoduodenal fistula

   • Fumio Chikamori
   • Kazuya Okumiya
   • Nobutoshi Kuniyoshi

   Case report Pages: 125 - 128

9. Primary intestinal lymphangiectasia successfully treated with octreotide

   • Ganji Kuroiwa
   • Tetsuji Takayama
   • Yoshiro Niitsu

   Case report Pages: 129 - 132

10. Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant

    • Takashi Someya
    • Yoshiyuki Suzuki
    • Hiromitsu Kumada

    Case report Pages: 133 - 136

11. What are the objectives of treatment for intestinal lymphangiectasia?

    • Hiroki Takahashi
    • Kohzoh Imai

    Editorial Pages: 137 - 138

12. Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B

    • Kendo Kiyosawa
    • Eiji Tanaka

    Editorial Pages: 139 - 141